SCHEMBL3295487

SCHEMBL3295487

CCCCOc1cc(CC)cc([SiH](O[SiH](c2cc(CC)cc(OCCCC)c2)c2cc(CC)cc(OCCCC)c2)c2cc(CC)cc(OCCCC)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.39
NR5A1 Q13285 1/20 0.39
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PLA2G2A P14555 1/20 0.35
TP53 P04637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
CYP2D6 P10635 2/20 0.34
CYP3A4 P08684 1/20 0.34
PLA2G4B P0C869 1/20 0.34
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
PDE4A P27815 1/20 0.33
HIF1A Q16665 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3302675 0.88 PLA2G2A (0.43) LTA4HNR5A1TSHRPLA2G2ATP53
SCHEMBL3298789 0.84 NQO1 (0.37) LTA4HTSHRSMN1; SMN2TP53LMNA
SCHEMBL5251054 0.82 LTA4H (0.48) LTA4HNR5A1TSHRSMN1; SMN2PLA2G2A
SCHEMBL3296785 0.81 TP53 (0.37) LTA4HNR5A1TSHRPLA2G2ATP53
SCHEMBL3299748 0.79 PTGS2 (0.39) TSHRALDH1A1
SCHEMBL3296274 0.78 PTGS2 (0.38) TP53
SCHEMBL3297593 0.78 CNR1 (0.37) LTA4HTSHRPLA2G2ATP53LMNA
SCHEMBL5269809 0.76 PLA2G2A (0.55) LTA4HNR5A1TSHRPLA2G2ATP53
SCHEMBL13261658 0.75 LTA4H (0.47) LTA4HNR5A1SMN1; SMN2PLA2G2AALDH1A1
SCHEMBL16953779 0.75 MAPT (0.45) LTA4HNR5A1SMN1; SMN2PLA2G2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 LTA4H 1866/4885NR5A1 595/4885TSHR 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.